This work identifies a unique mechanism by which HSPB1 is secreted from astrocytes in reactive conditions to mediate autocrine and paracrine neuroprotective functions and highlights the therapeutic potential of HSPB1 to ameliorate tau pathology in AD and related tauopathies. The gene discussed is MAPT; the disease is Alzheimer disease.